McKesson Corp Financial Update: Fiscal 2026 First Quarter Results and Profit Forecast

McKesson Corporation, a leading distribution company in the health care sector, has recently reported its fiscal 2026 first quarter results. The company, headquartered in Irving, Texas, specializes in supplying pharmaceuticals, medical-surgical supplies, and health and beauty care products across North America. Additionally, McKesson develops and supports software solutions for data integration within the health enterprise and offers analytic, care management, and patient solutions for payers.

Quarterly Performance and Earnings

In its first quarter report, McKesson Corp. announced a profit that, while decreased from the same period last year, exceeded Wall Street estimates. The company reported earnings of $784 million, or $6.25 per share, compared to $915 million, or $7.00 per share, in the previous year. Excluding certain items, McKesson’s adjusted earnings were $1.037 billion or $8.26 per share, surpassing analysts’ expectations of $8.15 per share.

Annual Profit Forecast

In a separate announcement, McKesson raised its annual profit forecast, attributing the adjustment to robust demand for specialty drugs. The company, traded on the New York Stock Exchange, expects per-share profit to be in the range of $37.10 to $37.50. This optimistic outlook is supported by high profit margins for specialty medicines, which treat complex conditions such as rheumatoid arthritis and cancer.

Market Performance and Investment Insights

As of August 4, 2025, McKesson’s stock closed at $709.49, with a 52-week high of $737.89 and a low of $464.42. The company’s market capitalization stands at approximately $86.63 billion, with a price-to-earnings ratio of 27.281. Investors looking to enhance their income from McKesson’s stock, which offers a 0.5% annualized dividend yield, can consider selling the January 2027 covered call at the $860 strike to collect a premium that annualizes to an additional 3.2% rate of return.

Historical Investment Performance

Reflecting on past performance, investors who purchased McKesson shares three years ago at $337.81 per share would have seen their investment grow to $698.80 per share, marking a significant increase in value.

Market Position and Outlook

McKesson’s strong interest coverage ratio, alongside companies like Disney, BJ’s Wholesale Club, and Ralph Lauren, positions it as an attractive investment in today’s volatile market. Analysts are also keenly watching the potential impact of GLP-1 demand on McKesson’s top line in the upcoming earnings season.

For more detailed information, investors and stakeholders can visit McKesson’s official website at www.mckesson.com .